Also trades as: LABS.TO (TSX) · $vol 0M
MEDIF OTC
MediPharm Labs Corp.
1W: +1.0%
1M: -3.6%
3M: +1.4%
YTD: +0.2%
1Y: -8.4%
3Y: -10.3%
5Y: -76.7%
$0.05
-0.00 (-3.40%)
Weekly Expected Move ±7.9%
$0
$0
$0
$0
$0
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$54M
-16.0% ▼
5Y CAGR: -20.5%
Total Liabilities
$11M
-3.5% ▼
5Y CAGR: -22.5%
Shareholders Equity
$43M
-18.5% ▼
5Y CAGR: -20.0%
Cash & Investments
$12M
-34.0% ▼
5Y CAGR: -21.0%
Total Debt
$388K
-83.1% ▼
5Y CAGR: -48.4%
Net Debt
-$11M
+27.9% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $20M | $34M | $24M | $18M | $12M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $185K |
| Cash & ST Investments | $20M | $34M | $24M | $18M | $12M |
| Net Receivables | $28M | $17M | $13M | $6M | $8M |
| Inventory | $22M | $11M | $8M | $10M | $9M |
| Other Current Assets | $9M | $3M | $2M | $2M | $4M |
| Total Current Assets | $82M | $66M | $47M | $37M | $33M |
| Property, Plant & Equip. | $34M | $26M | $18M | $25M | $19M |
| Goodwill & Intangibles | $228K | $44K | $39K | $1M | $854K |
| Long-Term Investments | $191K | $0 | $0 | $0 | $0 |
| Other Non-Current Assets | -$52K | $876K | -$18M | $1M | $635K |
| Total Non-Current Assets | $37M | $27M | $18M | $27M | $21M |
| Total Assets | $118M | $92M | $65M | $64M | $54M |
| — Liabilities — | |||||
| Accounts Payable | $6M | $3M | $4M | $2M | $4M |
| Short-Term Debt | $7M | $0 | $523K | $2M | $258K |
| Deferred Revenue | $1M | $1M | $1M | $0 | $607K |
| Other Current Liabilities | $2M | $2M | $2M | $2M | $3M |
| Total Current Liabilities | $24M | $9M | $9M | $11M | $10M |
| Long-Term Debt | $11M | $0 | $0 | $0 | $0 |
| Other Non-Current Liab. | $5M | $235K | $0 | $0 | $0 |
| Total Non-Current Liabilities | $16M | $338K | $34K | $69K | $51K |
| Total Liabilities | $40M | $9M | $9M | $11M | $11M |
| — Equity — | |||||
| Common Stock | $139M | $191M | $191M | $200M | $201M |
| Retained Earnings | -$75M | -$129M | -$164M | -$177M | -$187M |
| Accumulated OCI | $14M | $22M | $28M | $29M | $29M |
| Total Stockholders Equity | $78M | $83M | $56M | $53M | $43M |
| Total Liabilities & Equity | $118M | $92M | $65M | $64M | $54M |
| — Key Metrics — | |||||
| Total Debt | $18M | $216K | $632K | $2M | $388K |
| Net Debt | -$1M | -$34M | -$24M | -$16M | -$11M |
| Total Investments | $191K | $0 | $0 | $0 | $185K |